Giacomo Tanti
Rome, 00168, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Early and Late Response and Glucocorticoid-Sparing Effect of Belimumab in Patients with Systemic Lupus Erythematosus with Joint and Skin Manifestations: Results from the Belimumab in Real Life Setting Study-Joint and Skin (BeRLiSS-JS).
Journal: Journal of personalized medicine
Published: April 01, 2023
Simultaneous Onset of Mycobacterium kansasii Pulmonary Infection and Systemic Lupus Erythematosus: A Case Report.
Journal: The American journal of case reports
Published: May 19, 2021
Depression and Endothelial Dysfunction in Psoriatic Arthritis: Is There Any Possible Relationship?
Journal: Frontiers in medicine
Published: February 18, 2021
Psoriatic arthritis and depressive symptoms: does systemic inflammation play a role?
Journal: Clinical rheumatology
Published: May 19, 2020
Telemedicine will not keep us apart in COVID-19 pandemic.
Journal: Annals of the rheumatic diseases
Published: May 16, 2020
Rituximab Followed by Belimumab Controls Severe Lupus Nephritis and Bullous Pemphigoid in Systemic Lupus Erythematosus Refractory to Several Combination Therapies.
Journal: Frontiers in medicine
Published: April 17, 2020
No higher risk of respiratory symptoms in Italian rheumatological patients under IL-6R-inhibitor therapy in SARS-CoV-2 pandemic.
Journal: Rheumatology (Oxford, England)
Published: April 09, 2020
Early Disease and Low Baseline Damage as Predictors of Response to Belimumab in Patients With Systemic Lupus Erythematosus in a Real-Life Setting.
Journal: Arthritis & rheumatology (Hoboken, N.J.)
Published: October 20, 2019
Showing 1-8 of 8
Last Updated: 09/26/2026